198 related articles for article (PubMed ID: 27123533)
1. Giving Boys a Shot: The HPV Vaccine's Portrayal in Canadian Newspapers.
Perez S; Fedoruk C; Shapiro GK; Rosberger Z
Health Commun; 2016 Dec; 31(12):1527-38. PubMed ID: 27123533
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of human papillomavirus vaccine for males: a review of the literature.
Liddon N; Hood J; Wynn BA; Markowitz LE
J Adolesc Health; 2010 Feb; 46(2):113-23. PubMed ID: 20113917
[TBL] [Abstract][Full Text] [Related]
4. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles.
Abdelmutti N; Hoffman-Goetz L
Women Health; 2009; 49(5):422-40. PubMed ID: 19851946
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
6. HPV vaccine acceptance among adolescent males and their parents in two suburban pediatric practices.
Khurana S; Sipsma HL; Caskey RN
Vaccine; 2015 Mar; 33(13):1620-4. PubMed ID: 25659275
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
9. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women.
Sperber NR; Brewer NT; Smith JS
Cancer Causes Control; 2008 Feb; 19(1):115-8. PubMed ID: 17952620
[TBL] [Abstract][Full Text] [Related]
10. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
[TBL] [Abstract][Full Text] [Related]
11. Arguments in favor of and against the HPV vaccine school-entry requirement in Puerto Rico: a content analysis of newspaper media.
Vázquez-Otero C; Martinez Tyson D; Vamos CA; Romero-Daza N; Beckstead J; Daley EM
Cancer Causes Control; 2021 Aug; 32(8):793-802. PubMed ID: 33913078
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
13. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.
Dunne EF; Friedman A; Datta SD; Markowitz LE; Workowski KA
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S143-52. PubMed ID: 22080267
[TBL] [Abstract][Full Text] [Related]
14. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
15. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
16. Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine.
Bodemer N; Müller SM; Okan Y; Garcia-Retamero R; Neumeyer-Gromen A
Vaccine; 2012 May; 30(25):3747-56. PubMed ID: 22421558
[TBL] [Abstract][Full Text] [Related]
17. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
18. The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting.
Sharma M; Sy S; Kim JJ
BJOG; 2016 May; 123(6):917-26. PubMed ID: 26176301
[TBL] [Abstract][Full Text] [Related]
19. The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.
Sheinfeld Gorin SN; Glenn BA; Perkins RB
Adv Ther; 2011 Aug; 28(8):615-39. PubMed ID: 21818672
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of sexually transmitted HPV infection, genitoanal warts, cancer and their prevention among young females after vaccine introduction in Germany.
Kuznetsov AV; Müller RA; Ruzicka T; Herzinger T; Kuznetsov L
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1527-34. PubMed ID: 23216713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
